Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies.

Edward M KerwinLindsey MurrayXiaoli NiuCarole Dembek

Published in: International journal of chronic obstructive pulmonary disease (2020)

Nebulized GLY over 12 weeks significantly reduced the risk of CID and provided greater short-term stability in patients with moderate-to-very-severe COPD.

Keyphrases

placebo controlled
double blind
phase iii
chronic obstructive pulmonary disease
lung function
phase ii
clinical trial
study protocol
phase ii study
electronic health record
big data
open label
high intensity
early onset
randomized controlled trial
machine learning
radiation therapy